Merck’s settlement of Vioxx litigation with 29 states included agreements to abide by ACCME policies regarding disclosure of relationships between speakers and companies and not to fund programs featuring speakers who have spoken at a Merck-sponsored promotional event on a drug in the relevant class within the last 12 months. The settlement commits Merck to these conditions for nine years.
From the July 01, 2008 Issue of MM+M - Medical Marketing and Media
